May mimic other serious medical conditions such as myocardial infarction, appendicitis, acute cholecystitis, renal colic, pulmonary embolism or glaucoma
Lesson common manifestations include pneumonitis, acute retinal necrosis, myelitis, vasculopathy, hepatitis and meningoencephalitis
Complications
Postherpetic neuralgia
Secondary skin infection from Streptococcus pyogenes or S. aureas
Congenital infection – congenital VZV transmission may cause severe disseminated neonatal infection with:
Pneumonia
Skin lesions
Hemorrhages
Death
Diagnosis
Based on typical appearance of skin lesions
Chickenpox– skin lesions are in different stages of development (papule, vesicle, pustule, umbilication, and crusting)
Shingles – vesicles along a dermatonal distribution
In VZV-CNS syndromes where viral recovery from CSF is poor, PCR is recommended
Differential Diagnosis
Cutaneous (chickenpox) – HSV, smallpox, rickettsial pox and bullous impetigo
Cutaneous (Zoster) – HSV, contact dermatitis, poison ivy, poison oak and bullous impetigo
Viral encephalitis and meningitis
Treatment
Early treatment of zoster accelerates resolution and perhaps lessens post-herpetic pain
Prevention
Childhood vaccination preventive for VZV in most cases
Universal vaccination has decreased outbreaks and severity of secondary complications
New vaccine recently approved for adults >60 years to prevent herpes zoster
Vaccine shown to reduce the incidence of PHN by 66.5%
Given its expense, some laboratories may limit testing to:
- CNS syndromes
- Body fluids or tissues from unusual varicella or herpes zoster infections
- Vesicle fluid specimens negative for VZV by culture and/or DFA negative for herpes simplex virus by culture, where definitive etiologic determination clinically important
Varicella-Zoster Virus Antibody, IgG by ELISA (CSF) 0054444
Method: Enzyme-Linked Immunosorbent Assay
General References
Enright AM, Prober CG.Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus.Pediatr Clin North Am. 2004;51(4):889-908, viii. (Link to PubMed)
Gilden D.Varicella zoster virus and central nervous system syndromes.Herpes. 2004;11 Suppl 2:89A-94A. (Link to PubMed)
Grose C.Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.J Clin Virol. 2005;33(2):89-95. (Link to PubMed)
Hambleton S.Chickenpox.Curr Opin Infect Dis. 2005;18(3):235-240. (Link to PubMed)
Heininger U, Seward JF.Varicella.Lancet. 2006;368(9544):1365-1376. (Link to PubMed)
Nagel MA, Gilden DH.The protean neurologic manifestations of varicella-zoster virus infection.Cleve Clin J Med. 2007;74(7):489-489. (Link to PubMed)
Opstelten W, Zaal MJ.Managing ophthalmic herpes zoster in primary care.BMJ. 2005;331(7509):147-151. (Link to PubMed)
Vazquez M.Varicella infections and varicella vaccine in the 21st century.Pediatr Infect Dis J. 2004;23(9):871-872. (Link to PubMed)
Watson B.Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?.Expert Rev Anti Infect Ther. 2005;3(1):105-115. (Link to PubMed)
Welsby PD.Chickenpox, chickenpox vaccination, and shingles.Postgrad Med J. 2006;82(967):351-352. (Link to PubMed)
Reviewed by
Hillyard, David R., M.D. Medical Director, Molecular Infectious Diseases at ARUP Laboratories; Associate Professor, Pathology, University of Utah
Litwin, Christine, M.D. Medical Director, Immunology at ARUP Laboratories; Professor, Clinical Pathology, University of Utah
Petti, Cathy A., M.D. Medical Director, Infectious Diseases at ARUP Laboratories; Assistant Professor, Pathology and Medicine, University of Utah
Comprehensive Review: January 2008
Last Update: January 2008